Bioassay-guided purification and identification of PPARα/γ agonists from Chlorella sorokiniana

Phytotherapy Research

Volumn 22, Issue 5, 2008, Pages 605-613

  Chou, Yu Cheng ^a   Prakash, Ekambaranellore ^a   Huang, Chien Fu ^a,b   Lien, Tzu Wen ^a   Chen, Xin ^a   Su, Ih Jen ^a   Chao, Yu Sheng ^a   Hsieh, Hsing Pang ^a   Hsu, John Tsu An ^a,c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

C. sorokiniana; Peroxisome proliferator activated receptors alpha (PPAR ); Peroxisome proliferator activated receptors gamma (PPAR ); Scintillation proximity assay (SPA); Transcriptional activation (TA) assay

Indexed keywords

CHLORELLA SOROKINIANA EXTRACT; FATTY ACID; LINOLEIC ACID; LINOLENIC ACID; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST;

ARTICLE; ASSAY; BIOASSAY; CHLORELLA SOROKINIANA; DIABETES MELLITUS; DRUG ACTIVITY; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; LIGAND BINDING; MASS FRAGMENTOGRAPHY; NEOPLASM; OBESITY; PURIFICATION; REPORTER GENE; TRANSCRIPTION INITIATION;

ALPHA-LINOLENIC ACID; BIOLOGICAL ASSAY; CELL LINE, TUMOR; CHLORELLA; FATTY ACIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LINOLEIC ACID; PPAR ALPHA; PPAR GAMMA; TRANS-ACTIVATION (GENETICS);

CHLORELLA SOROKINIANA; CHLOROPHYTA;

EID: 44149093347     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2280     Document Type: Article

References (42)

1. Anandharajan RS, Jaiganesh NP, Shankernarayanan RA, Viswakarma A, Balakrishnan. 2006. In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPARgamma in L6 myotubes. Phytomedicine 13: 434-441.
2. Cheng PT, Mukherjee R. 2005. PPARs as targets for metabolic and cardiovascular diseases. Mini Rev Med Chem 5: 741-753.
3. Cherng JY, Shih MF. 2006. Improving glycogenesis in streptozotocin (STZ) diabetic mice after administration of green algae Chlorella. Life Sci 78: 1181-1186.
4. Grun F, Blumberg B. 2003. Identification of novel nuclear hormone receptor ligands by activity-guided purification. Methods Enzymol 364: 3-24.
5. Guzman S, Gato A, Calleja JM. 2001. Antiinflammatory, analgesic and free radical scavenging activities of the marine microalgae Chlorella stigmatophora and Phaeodactylum tricornutum. Phytother Res 15: 224-230.
6. Hogan P, Dall T, Nikolov P. 2003. Economic costs of diabetes in the US in 2002. Diabetes Care 26: 917-932.
7. Huang TH, Yang Q, Harada M et al. 2006. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes. Toxicol Appl Pharmacol 210: 78-85.
8. Jin DQ, Li G, Kim JS, Yong CS, Kim JA, Huh K. 2004. Preventive effects of Laminaria japonica aqueous extract on the oxidative stress and xanthine oxidase activity in streptozotocin-induced diabetic rat liver. Biol Pharm Bull 27: 1037-1040.
9. Jong-Yuh C, Mei-Fen S. 2005. Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice. Life Sci 77: 980-990.
10. Jungling E, Kammermeier H. 1988. A one-vial method for routine extraction and quantification of free fatty acids in blood and tissue by HPLC. Anal Biochem 171: 150-157.
11. Kittaka-Katsura H, Fujita T, Watanabe F, Nakano Y. 2002. Purification and characterization of a corrinoid compound from Chlorella tablets as an algal health food. J Agric Food Chem 50: 4994-4997.
12. Kliewer SA, Sundseth SS, Jones SA et al. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94: 4318-4323.
13. Lamela M, Anca J, Villar R, Otero J, Calleja JM. 1989. Hypoglycemic activity of several seaweed extracts. J Ethnopharmacol 27: 35-43.
14. Lee CH, Olson P, Evans RM. 2003. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144: 2201-2207.
15. Lee H, Lai J, Tung Y. 1977. Hypoglycemic action of Chlorella. Taiwan Yi Xue Hui Za Zhi 76: 272-276.
16. Li DD, Chen JH, Chen Q et al. 2005. Swietenia mahagony extract shows agonistic activity to PPAR(gamma) and gives ameliorative effects on diabetic db/db mice. Acta Pharmacol Sin 26: 220-222.
17. Li RW, Theriault AG, Au K et al. 2006. Citrus polymethoxylated flavones improve lipid and glucose homeostasis and modulate adipocytokines in fructose-induced insulin resistant hamsters. Life Sci 79: 365-373.
18. Lin RF, Huang TC. 2002. Comparative studies on heterotrophic growth of thermophilic Chlorella. J Taiwan Normal Univ Math Sci Technol 47: 31-40.
19. Lu IL, Huang CF, Peng YH et al. 2006. Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, x-ray crystallography, and in vitro/in vivo biological activities. J Med Chem 49: 2703-2712.
20. Mahindroo N, Huang CF, Peng YH et al. 2005. Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities. J Med Chem 48: 8194-8208.
21. Mahindroo N, Peng YH, Lin CH et al. 2006a. Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists. J Med Chem 49: 6421-6424.
22. Mahindroo N, Wang CC, Liao CC et al. 2006b. Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies. J Med Chem 49: 1212-1216.
23. Mangelsdorf DJ, Thummel C, Beato M et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
24. Moraes LA, Piqueras L, Bishop-Bailey D. 2006. Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther 110: 371-385.
25. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. 2003. Lifetime risk for diabetes mellitus in the United States. JAMA 290: 1884-1890.
26. Noda K, Ohno N, Tanaka K et al. 1996. A water-soluble antitumor glycoprotein from Chlorella vulgaris. Planta Med 62: 423-426.
27. Otles S, Pire R. 2001. Fatty acid composition of Chlorella and Spirulina microalgae species. J AOAC Int 84: 1708-1714.
28. Pershadsingh HA. 2004. Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis? Expert Opin Investig Drugs 13: 215-228.
29. Rau O, Wurglics M, Dingermann T, Abdel-Tawab M, Schubert-Zsilavecz M. 2006. Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor. Pharmazie 61: 952-956.
30. Rodriguez-Lopez M, Lopez-Quijada C. 1971. Plasma-glucose and plasma-insulin in normal and alloxanized rats treated with Chlorella. Life Sci II 10: 57-60.
31. Rosen ED. 2005. The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent Fatty Acids 73: 31-34.
32. Schluter A, Yubero P, Iglesias R, Giralt M, Villarroya F. 2002. The chlorophyll-derived metabolite phytanic acid induces white adipocyte differentiation. Int J Obes Relat Metab Disord 26: 1277-1280.
33. Sekiya K, Ohtani A, Kusano S. 2004. Enhancement of insulin sensitivity in adipocytes by ginger. Biofactors 22: 153-156.
34. Shibata S, Natori Y, Nishihara T et al. 2003. Antioxidant and anti-cataract effects of Chlorella on rats with streptozotocin-induced diabetes. J Nutr Sci Vitaminol (Tokyo) 49: 334-339.
35. Simopoulos AP. 2006. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomedicine Pharmacother 60: 502-507.
36. Singh S, Kate BN, Banerjee UC. 2005. Bioactive compounds from cyanobacteria and microalgae: an overview. Crit Rev Biotechnol 25: 73-95.
37. Tanaka K, Yamada A, Noda K, Shoyama Y, Kubo C, Nomoto K. 1997. Oral administration of a unicellular green algae, Chlorella vulgaris, prevents stress-induced ulcer. Planta Med 63: 465-466.
38. Tontonoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79: 1147-1156.
39. Trouba KJ, Wauson EM, Vorce RL. 2000. Sodium arsenite inhibits terminal differentiation of murine C3H 10T1/2 preadipocytes. Toxicol Appl Pharmacol 168: 25-35.
40. Willson TM, Brown PJ, Sternbach DD, Henke BR. 2000. The PPARs: from orphan receptors to drug discovery. J Med Chem 43: 527-550.
41. Wolfrum C, Borrmann CM, Borchers T, Spener F. 2001. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci USA 98: 2323-2328.
42. Xu ME, Xiao SZ, Sun YH, Ou-yang Y, Guan C, Zheng XX. 2006. A preadipocyte differentiation assay as a method for screening potential anti-type II diabetes drugs from herbal extracts. Planta Med 72: 14-19.